Francesca Barone
Fortune : 1 M $ au 31/08/2026
Fortune : 1 M $ au 31/08/2026
Francesca Barone is currently Chief Scientific Officer at Candel Therapeutics, Inc. since 2022.
Former positions include Director-Laboratories at the Institute of Translational Medicine, Associate Professor at the University of Birmingham from 2010 to 2019, and Head-Experimental Medicine at Senda Biosciences, Inc. from 2019 to 2021.
Education includes doctorates from Sapienza University of Rome and King's College London.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 29/06/2026 | 77 362 ( 0,1 % ) | 1 M $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CANDEL THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/11/2020 |
| Sociétés | Poste | Fin |
|---|---|---|
Senda Biosciences, Inc.
Senda Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics to treat diseases | Corporate Officer/Principal | 01/11/2021 |
University of Birmingham
University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/12/2019 |
Institute of Translational Medicine | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
University of Birmingham
University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sapienza University of Rome
Sapienza University of Rome Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
King's College London
King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Candel Therapeutics, Inc.
Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
Senda Biosciences, Inc.
Senda Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics to treat diseases | Health Technology |
Institute of Translational Medicine |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national